Cargando…
Alpha-D-glucan-based vaccine adjuvants: Current status and future perspectives
Nanoparticles (NPs) are increasingly used as efficient vaccine antigen-delivery platforms and vaccine adjuvants. Alpha (α)-D-glucans are polysaccharide polymers found in plants, animals, and microbes. Phytoglycogen (PG) is a densely branched dendrimer-like α-D-glucan that forms nanoparticle structur...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471374/ https://www.ncbi.nlm.nih.gov/pubmed/36119085 http://dx.doi.org/10.3389/fimmu.2022.858321 |
_version_ | 1784789059863838720 |
---|---|
author | Patil, Veerupaxagouda Hernandez-Franco, Juan F. HogenEsch, Harm Renukaradhya, Gourapura J. |
author_facet | Patil, Veerupaxagouda Hernandez-Franco, Juan F. HogenEsch, Harm Renukaradhya, Gourapura J. |
author_sort | Patil, Veerupaxagouda |
collection | PubMed |
description | Nanoparticles (NPs) are increasingly used as efficient vaccine antigen-delivery platforms and vaccine adjuvants. Alpha (α)-D-glucans are polysaccharide polymers found in plants, animals, and microbes. Phytoglycogen (PG) is a densely branched dendrimer-like α-D-glucan that forms nanoparticle structures. Two simple chemical modifications of corn-derived PG create positively charged, amphiphilic nanoparticles, known as Nano-11, that stimulate immune responses when used as vaccine adjuvant in a variety of species. Nano-11 is a versatile adjuvant that can be used for alternative routes of vaccination and in combination with other immunostimulatory molecules. This review discusses our current understanding of the mechanism of action of Nano-11 and its future potential applications in animal vaccines. |
format | Online Article Text |
id | pubmed-9471374 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94713742022-09-15 Alpha-D-glucan-based vaccine adjuvants: Current status and future perspectives Patil, Veerupaxagouda Hernandez-Franco, Juan F. HogenEsch, Harm Renukaradhya, Gourapura J. Front Immunol Immunology Nanoparticles (NPs) are increasingly used as efficient vaccine antigen-delivery platforms and vaccine adjuvants. Alpha (α)-D-glucans are polysaccharide polymers found in plants, animals, and microbes. Phytoglycogen (PG) is a densely branched dendrimer-like α-D-glucan that forms nanoparticle structures. Two simple chemical modifications of corn-derived PG create positively charged, amphiphilic nanoparticles, known as Nano-11, that stimulate immune responses when used as vaccine adjuvant in a variety of species. Nano-11 is a versatile adjuvant that can be used for alternative routes of vaccination and in combination with other immunostimulatory molecules. This review discusses our current understanding of the mechanism of action of Nano-11 and its future potential applications in animal vaccines. Frontiers Media S.A. 2022-08-31 /pmc/articles/PMC9471374/ /pubmed/36119085 http://dx.doi.org/10.3389/fimmu.2022.858321 Text en Copyright © 2022 Patil, Hernandez-Franco, HogenEsch and Renukaradhya https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Patil, Veerupaxagouda Hernandez-Franco, Juan F. HogenEsch, Harm Renukaradhya, Gourapura J. Alpha-D-glucan-based vaccine adjuvants: Current status and future perspectives |
title | Alpha-D-glucan-based vaccine adjuvants: Current status and future perspectives |
title_full | Alpha-D-glucan-based vaccine adjuvants: Current status and future perspectives |
title_fullStr | Alpha-D-glucan-based vaccine adjuvants: Current status and future perspectives |
title_full_unstemmed | Alpha-D-glucan-based vaccine adjuvants: Current status and future perspectives |
title_short | Alpha-D-glucan-based vaccine adjuvants: Current status and future perspectives |
title_sort | alpha-d-glucan-based vaccine adjuvants: current status and future perspectives |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471374/ https://www.ncbi.nlm.nih.gov/pubmed/36119085 http://dx.doi.org/10.3389/fimmu.2022.858321 |
work_keys_str_mv | AT patilveerupaxagouda alphadglucanbasedvaccineadjuvantscurrentstatusandfutureperspectives AT hernandezfrancojuanf alphadglucanbasedvaccineadjuvantscurrentstatusandfutureperspectives AT hogeneschharm alphadglucanbasedvaccineadjuvantscurrentstatusandfutureperspectives AT renukaradhyagourapuraj alphadglucanbasedvaccineadjuvantscurrentstatusandfutureperspectives |